Squarepoint’s Acrivon Therapeutics ACRV Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$182K	Buy	+152,605	New	+$182K	﹤0.01%	2367
2024 Q3	–	Sell	-17,207	Closed	-$99.8K	–	2498
2024 Q2	$99.8K	Buy	+17,207	New	+$99.8K	﹤0.01%	2267